Young Richard A 4
4 · Camp4 Therapeutics Corp · Filed Oct 15, 2024
Insider Transaction Report
Form 4
Young Richard A
Director
Transactions
- Conversion
Common Stock
2024-10-15+8,917→ 154,859 total - Conversion
Series A Prime Preferred Stock
2024-10-15−100,014→ 0 total→ Common Stock (8,917 underlying)
Footnotes (1)
- [F1]On October 15, 2024, the shares of Series A Prime Convertible Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering.